Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature

Background: Anti-IgLON5 disease is a novel disorder with a complex interplay between inflammation and neurodegeneration. Patients develop antibodies against IgLON5 but also deposition of neuronal tau protein. Symptoms often have an insidious onset, slow progression and mimic other neurological disor...

Full description

Bibliographic Details
Main Authors: Mette Scheller Nissen, Morten Blaabjerg
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2019.01056/full